Codexis signs evaluation agreement with Axolabs
Codexis signs agreement for cardiovascular indication
Transform complex, resource-intensive processes into precise, sustainable breakthroughs with biocatalysis that scales from grams to tonnes
Evolve beyond solid-phase oligonucleotide synthesis (SPOS) with a modern and efficient approach that delivers higher quality, greater scale, and better manufacturability
Precision-tuned enzyme solutions enhance fidelity, selectivity, and activity for applications that demand superior performance
View Upcoming Events